Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Chiesi Foundation Onlus Issues 2018 Call for Scientific Research Proposals


Posted on: 14 Aug 18

Scientists and researchers are invited to submit proposals for Research in neonatology and pulmonology

CARY, N.C., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Chiesi Foundation Onlus (key-A-zee) announced its 2018 Call for Scientific Research Proposals in the fields of neonatology and pulmonology. The Foundation strongly encourages proposals that advance understanding of these fields through highly productive, collaborative teams with multi-disciplinary expertise.

Founded in 2005, the Chiesi Foundation is a nonprofit organization that leverages the abundant knowledge of Chiesi Farmaceutici to promote health and alleviate suffering among patients affected by chronic respiratory and neonatal diseases. To achieve this mission, the Chiesi Foundation annually grants financial support to projects focused on neonatology and pulmonology scientific research and international cooperation.

“This opportunity will boost the scientific and medical community’s ability to conduct quality research in these important fields,” said Ken McBean, President and Chief Executive Officer of Chiesi USA. “Working in tandem with our Chiesi in the Community corporate social responsibility initiative, the Chiesi Foundation’s Call for Scientific Research Proposals is yet another example of Chiesi’s commitment to leave a lasting impact on the local and global community.”

Neonatology proposals should aim to improve knowledge of factors affecting neonatal disease progression and identify strategies to prevent or minimize long-term consequences, thus ensuring better quality of life for affected babies and their families. Pulmonology proposals should aim to shed light on the interaction between environmental and socioeconomic factors and the respiratory system, as well as foster the communication of scientific messages using digital tools.

The submission deadlines are October 15, 2018, for neonatology and November 15, 2018, for pulmonology. Detailed information on the proposal scope, submission process and grant rules can be found at Chiesi Foundation Call for Research Proposals 2018.

The Chiesi Foundation is a distinct entity from Chiesi USA, therefore, inquiries regarding the Chiesi Foundation and/or the Call for Scientific Research Proposals should be directed to the Chiesi Foundation team at info@chiesifoundation.org.

About Chiesi Foundation Onlus
Chiesi Foundation Onlus (hereinafter referred to as the “Foundation”) is a private, nonprofit organization. The scope of the Foundation is to promote, encourage and advance medical research worldwide. The Foundation does not directly conduct medical research. It supports medical research by providing annual grants for basic and clinical research on lung diseases, with particular attention to bronchial asthma and chronic obstructive pulmonary diseases (COPD), neonatal diseases and on other relevant scientific areas. To learn more, visit www.chiesifoundation.org/en/.

About Chiesi USA
Chiesi USA, Inc., headquartered in Cary, N.C., is a specialty pharmaceutical company focused on commercialization of products for the hospital, rare disease and target office-based specialties. Key elements of the company’s strategy are to focus its commercial and development efforts in the hospital and adjacent specialty product sector within the U.S. pharmaceutical marketplace; continue to seek opportunities to acquire companies, marketed or registration-stage products and late-stage development products that fit within the Company's focus areas. Chiesi USA, Inc. is a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. For more information, visit www.chiesiusa.com.

About Chiesi in the Community
Chiesi in the Community is Chiesi USA’s employee-led corporate social responsibility program. The mission of the program is to improve the health and well-being of the communities where we live and serve. The program is comprised of four main pillars: Stakeholder Engagement, Local Sociocultural Enhancement, Therapeutic Areas and Keystone Initiative. Chiesi works with many nonprofits in the Triangle area focused on underserved youth. In addition to local nonprofit support, the company’s Keystone Initiative is focused on local elementary schools; working with staff, parents and local partners to implement sustainable programs designed to make positive change in the overall student learning experience. On a national scale, Chiesi continues to support the efforts of groups within the therapeutic areas they serve, such as the March of Dimes, American Heart Association and cystic fibrosis nonprofits.

About Chiesi Farmaceutici S.p.A.
Based in Parma, Italy, Chiesi Farmaceutici is an international research-focused Healthcare Group, with over 80 years of experience in the pharmaceutical industry, present in 27 countries. Chiesi researches, develops and markets innovative drugs in the respiratory therapeutics, specialist medicine and rare disease areas. Its R&D organization is headquartered in Parma (Italy), and integrated with 6 other key R&D groups in France, the USA, the UK, Sweden, and Denmark to advance Chiesi's pre-clinical, clinical and registration programs. Chiesi employs more than 5,300 people. For more information, please visit www.chiesi.com.

Contacts
Media: FleishmanHillard, Elizabeth Romero, +1-919-457-0749, elizabeth.romero@fleishman.com
Business Development: Josh Franklin, +1-919-678-6520, josh.franklin@chiesi.com

PP-G-0219 V1.0

GlobeNewswire
globenewswire.com

Last updated on: 14/08/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.